CollimateHealth raises €6M for hair-thin radiation beams to target cancer cells

CollimateHealth raised €6 million in seed funding to develop ultra-narrow X-ray beams tens of micrometres wide, about human hair thickness, aiming to treat cancer with less damage to healthy tissue. The beams trigger immune response and improve drug delivery, with first patients expected by end of 2028. Funding came from HTGF, VP Venture Partners, Positron, XISTA Science Ventures, and caesar.